• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Binding energetics of phosphorus-containing inhibitors of thermolysin.

作者信息

Grobelny D, Goli U B, Galardy R E

机构信息

Department of Biochemistry, University of Kentucky, Lexington 40536.

出版信息

Biochemistry. 1989 Jun 13;28(12):4948-51. doi: 10.1021/bi00438a006.

DOI:10.1021/bi00438a006
PMID:2765520
Abstract

The importance of a specific hydrogen bond between thermolysin and a phosphonamidate inhibitor, Z-NHCH2-PO(O-)-Leu-Leu (1) [Bartlett, P. A., & Marlowe, C. K. (1987) Science (Washington D.C.) 235, 569-571], has been reevaluated. We have determined the inhibition constants (binding free energies) for thermolysin of phosphonamidate n-hexyl-P(O)(O-)-Leu-Trp-NHMe (4), phosphonate n-hexyl-P-(O)(O-)OCH(iBu)CO-Trp-NHMe (5), and phosphinates n-hexyl-P(O)(O-)CH2CH(iBu)CO-Trp-NHMe (6) and Z-NHCH2PO(O-)CH2CH(iBu)CO-Leu (3). Replacement of the P-NH group by P-CH2 (1----3 and 4----6) weakens the overall binding free energy by about 1.5 kcal/mol. A negligible difference in solvation energy has been measured for these pairs, and the basicity of the P-O- ligand for zinc in each pair remains nearly unchanged as determined by pH titration of their 31P NMR resonances. Therefore, this value of 1.5 kcal/mol can be assigned to the specific hydrogen bond known to exist between the P-NH of 1 and thermolysin [Tronrud, D. E., Holden, H. M., & Matthews, B. W. (1987) Science (Washington, D.C.) 235, 871-574] and inferred to exist between 4 and the enzyme. Substitution of P-O for P-NH (1----2 [Bartlett, P. A., & Marlowe, C. K. (1987) Science (Washington, D.C.) 235, 569-571] and 4----5) weakens the overall binding free energy by 4.1 kcal/mol for each pair as the basicity of the P-O- ligand decreases by about 1.6 pH units. The measured solvation energy difference between 4 and 5 (and by inference between 1 and 2) is negligible.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Binding energetics of phosphorus-containing inhibitors of thermolysin.
Biochemistry. 1989 Jun 13;28(12):4948-51. doi: 10.1021/bi00438a006.
2
Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues.嗜热菌蛋白酶的慢结合和快结合抑制剂表现出不同的结合模式:扩展膦酰胺过渡态类似物的晶体学分析
Biochemistry. 1987 Dec 29;26(26):8542-53. doi: 10.1021/bi00400a008.
3
Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor.
Science. 1987 Jan 30;235(4788):569-71. doi: 10.1126/science.3810155.
4
Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin.水离解在嗜热菌蛋白酶含磷过渡态类似物抑制剂缓慢结合中的可能作用。
Biochemistry. 1987 Dec 29;26(26):8553-61. doi: 10.1021/bi00400a009.
5
Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.采用泊松-玻尔兹曼方法研究含磷抑制剂与嗜热菌蛋白酶的结合。
Protein Sci. 1995 Mar;4(3):373-81. doi: 10.1002/pro.5560040303.
6
Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues.与青霉素胃蛋白酶结合的过渡态模拟物的晶体学分析:含磷肽类似物
Biochemistry. 1992 Jun 9;31(22):5201-14. doi: 10.1021/bi00137a016.
7
Inhibition of thermolysin by phosphonamidate transition-state analogues: measurement of 31P-15N bond lengths and chemical shifts in two enzyme-inhibitor complexes by solid-state nuclear magnetic resonance.
Biochemistry. 1990 Oct 2;29(39):9176-84. doi: 10.1021/bi00491a011.
8
Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin.磷酰胺酯作为嗜热菌蛋白酶抑制剂和过渡态类似物的晶体结构分析
Eur J Biochem. 1986 Jun 2;157(2):261-8. doi: 10.1111/j.1432-1033.1986.tb09664.x.
9
Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond.
Science. 1987 Jan 30;235(4788):571-4. doi: 10.1126/science.3810156.
10
A theoretical investigation of tight-binding thermolysin inhibitors.紧密结合的嗜热菌蛋白酶抑制剂的理论研究
J Med Chem. 1997 Aug 29;40(18):2953-8. doi: 10.1021/jm9606958.

引用本文的文献

1
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.次膦酸肽作为研究药理学相关锌金属蛋白酶的工具化合物。
ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9.
2
Efficient Entropy-Driven Inhibition of Dipeptidyl Peptidase III by Hydroxyethylene Transition-State Peptidomimetics.高效的二肽基肽酶 III 抑制物:羟亚乙基过渡态肽模拟物。
Chemistry. 2021 Oct 7;27(56):14108-14120. doi: 10.1002/chem.202102204. Epub 2021 Aug 31.
3
IRAP Inhibitors: M1-Aminopeptidase Family Inspiration.
IRAP抑制剂:M1-氨基肽酶家族的启发。
Front Pharmacol. 2020 Sep 25;11:585930. doi: 10.3389/fphar.2020.585930. eCollection 2020.
4
A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria.脲酶抑制剂作为抗病原菌抗菌剂的发展综述。
J Adv Res. 2018 May 4;13:69-100. doi: 10.1016/j.jare.2018.05.003. eCollection 2018 Sep.
5
Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.2',3'-o-(N-甲基邻氨基苯甲酰基)-次黄苷 5'-三磷酸对哺乳动物膜腺苷酸环化酶高亲和力抑制的结构基础。
Mol Pharmacol. 2011 Jul;80(1):87-96. doi: 10.1124/mol.111.071894. Epub 2011 Apr 15.
6
Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.次膦酸肽是最早发现的虾红素蛋白酶强效抑制剂,表现为极慢结合型抑制剂。
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):375-9. doi: 10.1042/bj3310375.
7
Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.次膦酸肽类似物作为鼠棒状杆菌细菌胶原酶的有效抑制剂。
Biochem J. 1994 Oct 1;303 ( Pt 1)(Pt 1):323-7. doi: 10.1042/bj3030323.
8
Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.采用泊松-玻尔兹曼方法研究含磷抑制剂与嗜热菌蛋白酶的结合。
Protein Sci. 1995 Mar;4(3):373-81. doi: 10.1002/pro.5560040303.